国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2015年
8期
1116-1118
,共3页
姜媛媛%李福青%王琳%杜晓林%张金平
薑媛媛%李福青%王琳%杜曉林%張金平
강원원%리복청%왕림%두효림%장금평
功能性消化不良%多潘立酮%复方消化酶%临床疗效
功能性消化不良%多潘立酮%複方消化酶%臨床療效
공능성소화불량%다반립동%복방소화매%림상료효
Functional dyspepsia%Domperidone%Compound digestive enzymes%Clinical efficacy
目的 探讨采用多潘立酮联合复方消化酶对功能性消化不良进行治疗的临床效果.方法 随机选取我院2011年3月至2014年4月期间收治的功能性消化不良患者256例,按照给药方法的不同,将所选取的患者分配为实验组和对照组,其中对照组患者单纯采用多潘立酮进行治疗,实验组患者在对照组的给药基础上加用复方消化酶进行治疗,对比两组患者的临床治疗效果.结果 实验组患者的临床疗效明显优于对照组患者(P<0.05),且两组患者不良反应的发生情况无明显差异(P> 0.05).结论 采用多潘立酮联合复方消化酶对功能性消化不良患者进行治疗,疗效显著,安全可靠,建议在临床上进一步推广.
目的 探討採用多潘立酮聯閤複方消化酶對功能性消化不良進行治療的臨床效果.方法 隨機選取我院2011年3月至2014年4月期間收治的功能性消化不良患者256例,按照給藥方法的不同,將所選取的患者分配為實驗組和對照組,其中對照組患者單純採用多潘立酮進行治療,實驗組患者在對照組的給藥基礎上加用複方消化酶進行治療,對比兩組患者的臨床治療效果.結果 實驗組患者的臨床療效明顯優于對照組患者(P<0.05),且兩組患者不良反應的髮生情況無明顯差異(P> 0.05).結論 採用多潘立酮聯閤複方消化酶對功能性消化不良患者進行治療,療效顯著,安全可靠,建議在臨床上進一步推廣.
목적 탐토채용다반립동연합복방소화매대공능성소화불량진행치료적림상효과.방법 수궤선취아원2011년3월지2014년4월기간수치적공능성소화불량환자256례,안조급약방법적불동,장소선취적환자분배위실험조화대조조,기중대조조환자단순채용다반립동진행치료,실험조환자재대조조적급약기출상가용복방소화매진행치료,대비량조환자적림상치료효과.결과 실험조환자적림상료효명현우우대조조환자(P<0.05),차량조환자불량반응적발생정황무명현차이(P> 0.05).결론 채용다반립동연합복방소화매대공능성소화불량환자진행치료,료효현저,안전가고,건의재림상상진일보추엄.
Objective To explore the clinical effect of domperidone combined with compound digestive enzymes in the treatment of functional dyspepsia.Methods 256 cases of functional dyspepsia in our hospital from March 2011 to April 2014 were randomly selected and divided into experimental group and control group according to different administration methods.Control group received domperidone,and experimental group received compound digestive enzymes on the basis of control group.Compared clinical outcomes of two groups.Results The clinical efficacy in experimental group was significantly better than that in control group (P<0.05),but there was no statistically significant difference in the incidence of adverse reactions between two groups (P>0.05).Conclusion Domperidone combined with compound digestive enzymes in the treatment of functional dyspepsia has a good effect,safe and reliable,worthy of clinical promotion.